Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MEDP · against 596 other Healthcare companies listed in US-listed
Ranked #390 of 597 · scores higher than 35% of peers · safety percentile 26
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)59 peers with a safety percentile of 20–29, including MEDP · Click a bar to see the companies
Mainly because of its current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MEDP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.33× | 0.23× | 45% | 33% | |
| BetaLower is better · 556 reported | 1.18 | 0.95 | 36% | 33% | |
| Current ratioHigher is better · 600 reported | 0.73× | 3.91× | 2% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 386 | 89.7B USD | 27 | 50 | |
| 387 | 7.2B USD | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 43 |
| 388 | 1.5B USD | 26 | 63 |
| 389 | 3.8B USD | 26 | 71 |
| 390 | 18.5B USD | 26 | 62 |
| 391 | 28.7B USD | 26 | 52 |
| 392 | 399M USD | 26 | 32 |
| 393 | 50.2B USD | 25 | 49 |
| 394 | 1.7B USD | 25 | 44 |